Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2021 May 1;397(10285):1620-1621.
doi: 10.1016/S0140-6736(21)00274-9.

Multiple myeloma triplet therapies: baseline characteristics and control groups

Ghulam Rehman Mohyuddin  1 , Al-Ola Abdallah  2 , Brian McClune  3 , Aaron Goodman  4 , Vinay Prasad  5
Affiliations
Free article
Comment

Multiple myeloma triplet therapies: baseline characteristics and control groups

Ghulam Rehman Mohyuddin et al. Lancet. .
Free article
No abstract available

PubMed Disclaimer

Conflict of interest statement

VP reports royalties from Johns Hopkins Press, Medscape, and MedPage; consulting for UnitedHealthcare; speaking fees for Evicore; has a plenary session podcast that has Patreon backers; and is funded to study low-value drugs through a grant from Arnold Ventures. AG reports consulting for Seattle Genetics and EUSA Pharma. All other authors declare no competing interests.

Comment on

  • Once-per-week selinexor, bortezomib, and dexamethasone versus twice-per-week bortezomib and dexamethasone in patients with multiple myeloma (BOSTON): a randomised, open-label, phase 3 trial.
    Grosicki S, Simonova M, Spicka I, Pour L, Kriachok I, Gavriatopoulou M, Pylypenko H, Auner HW, Leleu X, Doronin V, Usenko G, Bahlis NJ, Hajek R, Benjamin R, Dolai TK, Sinha DK, Venner CP, Garg M, Gironella M, Jurczyszyn A, Robak P, Galli M, Wallington-Beddoe C, Radinoff A, Salogub G, Stevens DA, Basu S, Liberati AM, Quach H, Goranova-Marinova VS, Bila J, Katodritou E, Oliynyk H, Korenkova S, Kumar J, Jagannath S, Moreau P, Levy M, White D, Gatt ME, Facon T, Mateos MV, Cavo M, Reece D, Anderson LD Jr, Saint-Martin JR, Jeha J, Joshi AA, Chai Y, Li L, Peddagali V, Arazy M, Shah J, Shacham S, Kauffman MG, Dimopoulos MA, Richardson PG, Delimpasi S. Grosicki S, et al. Lancet. 2020 Nov 14;396(10262):1563-1573. doi: 10.1016/S0140-6736(20)32292-3. Lancet. 2020. PMID: 33189178 Clinical Trial.

MeSH terms